{"ok":true,"article":{"slug":"psmaddition-trial-of-upfront-lutetium-177-psma-617-in-metastatic-hormone-sensiti-f0219ee4","title":"PSMAddition Trial of Upfront Lutetium-177-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer - Andrew Armstrong","url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNSk53QURBV1U1aG5JaFR6ZEhvaTVuTXpxMV9TaERRYm0wTENUakI5dm02eUVZZ2F2ZmFpUENzODdxRkpnYnd6VURfeVpma28wTERqSHEyTDZzc3ZIZE5TU3p2RURVWlplYzgzZ2pCZmpVQTBQaUNaenpUTVBlV1B1aFgxOUFzaGgwN256czdQblZRRUczdkN5ZWlSU250Nlg5cnhDUHg0aDgyV0c4NDlQMk4tSTVlek1DQlBBREE4aGxRNTJ5NEJYeE9wa3dydXNLbDFnSDdVek15RUx0MV9kMlNpblo3ZkNCTmlMZVAwMVRWVlI2V1YzeF91cXlCYmdRX0Mwak5UUms?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/psmaddition-trial-of-upfront-lutetium-177-psma-617-in-metastatic-hormone-sensiti-f0219ee4","sourceName":"UroToday","summary":"Related coverage: PSMAddition Trial of Upfront Lutetium-177-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer - Andrew Armstrong UroToday","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-12T22:32:10+00:00","createdAt":"2026-08-12T23:00:12.811666+00:00"}}